Home > Rheumatology > EULAR 2019 > Axial Spondyloarthritis > Treat-to-target Approach Emerging in Axial Spondyloarthritis

Treat-to-target Approach Emerging in Axial Spondyloarthritis

Presented By
Dr Pedro Machado, University College London Hospitals, United Kingdom
Conference
EULAR 2019
Trial
TICOPA, TICORA, TICOSPA

Observational evidence suggests that a treat-to-target (T2T) approach might be beneficial in axial spondyloarthritis. However, data from a prospective randomised study showing the efficacy of a T2T strategy compared to routine care are currently lacking. Additionally, there is no consensus about what should be measured and its specific target. These were the take-home messages presented by Dr Pedro Machado (University College London Hospitals, United Kingdom) discussing the pros and cons of adopting a T2T strategy in the management of axial spondyloarthritis [1].

The availability of biologic therapies has improved the clinical outcomes of patients with axial spondyloarthritis, which has raised the question if there is a role for T2T. Dr Machado explained that the concept involves changing or escalating therapy according to a predefined target, under the assumption that this may lead to better outcome compared to routine care. T2T is not only well establish...



please login to read the entire article:


You need to register to read the entire article, please do so now.





Posted on